Floatz logo

Rpm Cd19-Mbil15-Car-T Cells

Primary Mediastinal Large B-Cell Lymphoma

Eden BioCell Ltd.Cell therapyPhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

87 Active assets in the Primary Mediastinal Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
David Bond, MD
Phase 4BBB
ETOPOSIDE
University of Washington
Phase 4BBB
Inno-206
University of Washington
Phase 4BBB
Cyclophosphamide
University of Washington
Phase 4BBB
Fludarabine
Paolo Caimi, MD
Phase 2BBB

View all 50 →

Same molecule, other indications

Rpm Cd19-Mbil15-Car-T Cells is also rated in:

non-Hodgkin lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
Non-Hodgkin's Lymphoma RefractoryDormant
CC
Indicative ·
43 / 100
View asset →
B-cell acute lymphoblastic leukemiaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →